CING Earnings Date: Nov 12, 2026 (Estimated) — Cingulate Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is CING's next earnings date?
Cingulate Inc. (CING) is expected to report Q3 2026 earnings on Thursday, November 12, 2026 at 8:00 AM ET (before market open); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.48 on revenue of $540,000.
How did CING do in its last earnings report?
In its most recent report on Aug 13, 2026 (Q2 2026), Cingulate Inc. posted EPS of -$0.45 versus the -$0.63 estimate, a beat of 22.4%. Revenue was $0 against a $166,667 estimate. The stock's 1-day post-earnings move was -4.2%.
How much does CING stock move after earnings?
CING beat EPS estimates in 5 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 12.1% (up or down) in the day after earnings.
About Cingulate Inc.
Cingulate Inc. is a biopharmaceutical enterprise currently in its clinical development phase, dedicated to devising therapeutic options for attention-deficit/hyperactivity disorder (ADHD). Leading its pipeline for ADHD are two drug candidates: CTx-1301 (dexmethylphenidate), which is currently progressing through Phase 3 clinical trials, and CTx-1302 (dextroamphetamine). The company is also engaged in the advancement of CTx-2103, a candidate intended for the management of anxiety disorders. Founded in 2012, Cingulate Inc. maintains its corporate headquarters in Kansas City, Kansas.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-13 | Q2 2026 | -0.63 | -0.45 | +22.41% | $0 | ✅ Beat | -4.22% | +1.15% | -3.65% |
| 2026-05-14 | Q1 2026 | -0.53 | -0.95 | -79.25% | $0 | ❌ Miss | -10.77% | -5.89% | -0.81% |
| 2026-03-18 | Q4 2025 | -1.15 | -0.84 | +26.96% | $0 | ✅ Beat | -31.05% | -42.45% | -54.89% |
| 2025-11-13 | Q3 2025 | -0.77 | -1.35 | -75.32% | $0 | ❌ Miss | -12.37% | -10.00% | +16.84% |
| 2025-08-19 | Q2 2025 | -0.82 | -1.09 | -32.93% | $0 | ❌ Miss | -9.62% | +1.08% | -11.06% |
| 2025-03-26 | Q4 2024 | -1.49 | -0.14 | +90.60% | $0 | ✅ Beat | +5.07% | +0.48% | +3.86% |
| 2024-11-07 | Q3 2024 | -2.36 | -1.83 | +22.46% | $0 | ✅ Beat | +2.38% | +28.87% | +27.38% |
| 2024-08-13 | Q2 2024 | -5.64 | -5.47 | +3.01% | $0 | ✅ Beat | -21.06% | +349.11% | +128.41% |
Showing last 8 quarters.